Quest Diagnostics Incorporated Stock Current Liabilities

DGX Stock

USD 175.41 1.35 0.78%

Quest Diagnostics Incorporated fundamentals help investors to digest information that contributes to Quest Diagnostics' financial success or failures. It also enables traders to predict the movement of Quest Stock. The fundamental analysis module provides a way to measure Quest Diagnostics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Quest Diagnostics stock.

Short Long Term Debt Total Total Assets

Non Current Liabilities Total is likely to rise to about 7.4 B in 2025, whereas Total Current Liabilities is likely to drop slightly above 1.3 B in 2025.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Quest Diagnostics Incorporated Company Current Liabilities Analysis

Quest Diagnostics' Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.

Current Liabilities

Payables

+

Accrued Debt

More About Current Liabilities | All Equity Analysis

Current Quest Diagnostics Current Liabilities

1.17 B

Most of Quest Diagnostics' fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Quest Diagnostics Incorporated is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Quest Current Liabilities Driver Correlations

Understanding the fundamental principles of building solid financial models for Quest Diagnostics is extremely important. It helps to project a fair market value of Quest Stock properly, considering its historical fundamentals such as Current Liabilities. Since Quest Diagnostics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Quest Diagnostics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Quest Diagnostics' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Intangible Assets	Long Term Debt	Property Plant Equipment	Good Will	Treasury Stock	Current Deferred Revenue	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Long Term Investments	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.99	0.66	0.86	0.29	0.94	0.99	0.87	0.39	0.79	0.87	0.96	0.66	0.97	-0.77	0.51	0.35	0.83	0.28	0.18	-0.14	0.31	0.64	0.42	-0.05
Total Stockholder Equity	0.99		0.61	0.87	0.23	0.96	0.95	0.88	0.3	0.76	0.82	0.92	0.65	0.94	-0.8	0.5	0.43	0.82	0.31	0.26	-0.24	0.33	0.6	0.48	-0.01
Net Debt	0.66	0.61		0.84	0.79	0.56	0.7	0.48	0.68	0.59	0.73	0.74	0.82	0.76	-0.61	0.51	0.0	0.73	0.38	-0.14	0.3	0.11	0.75	-0.03	-0.72
Retained Earnings	0.86	0.87	0.84		0.52	0.82	0.82	0.74	0.48	0.67	0.74	0.82	0.79	0.87	-0.89	0.52	0.37	0.82	0.53	0.24	-0.04	0.33	0.69	0.3	-0.41
Accounts Payable	0.29	0.23	0.79	0.52		0.25	0.33	0.25	0.55	0.1	0.51	0.38	0.74	0.35	-0.18	0.47	0.11	0.58	0.41	-0.29	0.41	0.13	0.81	-0.04	-0.94
Net Receivables	0.94	0.96	0.56	0.82	0.25		0.89	0.93	0.3	0.68	0.75	0.83	0.66	0.87	-0.7	0.53	0.5	0.78	0.27	0.17	-0.31	0.46	0.61	0.65	-0.03
Total Liab	0.99	0.95	0.7	0.82	0.33	0.89		0.83	0.47	0.8	0.9	0.97	0.65	0.97	-0.72	0.5	0.27	0.83	0.25	0.09	-0.04	0.27	0.66	0.36	-0.08
Total Current Assets	0.87	0.88	0.48	0.74	0.25	0.93	0.83		0.38	0.54	0.64	0.74	0.62	0.74	-0.6	0.63	0.65	0.76	0.3	0.17	-0.16	0.7	0.68	0.77	-0.04
Short Term Debt	0.39	0.3	0.68	0.48	0.55	0.3	0.47	0.38		0.26	0.52	0.39	0.5	0.42	-0.35	0.3	0.0	0.45	0.39	-0.12	0.7	0.38	0.62	-0.03	-0.52
Common Stock	0.79	0.76	0.59	0.67	0.1	0.68	0.8	0.54	0.26		0.68	0.84	0.28	0.86	-0.72	0.28	-0.15	0.44	0.21	0.16	-0.09	0.04	0.21	0.08	0.02
Intangible Assets	0.87	0.82	0.73	0.74	0.51	0.75	0.9	0.64	0.52	0.68		0.91	0.63	0.89	-0.61	0.35	0.13	0.81	0.37	0.07	0.11	0.08	0.71	0.13	-0.26
Long Term Debt	0.96	0.92	0.74	0.82	0.38	0.83	0.97	0.74	0.39	0.84	0.91		0.63	0.98	-0.73	0.46	0.18	0.83	0.29	0.13	-0.07	0.15	0.63	0.24	-0.15
Property Plant Equipment	0.66	0.65	0.82	0.79	0.74	0.66	0.65	0.62	0.5	0.28	0.63	0.63		0.67	-0.46	0.66	0.38	0.84	0.19	-0.24	0.06	0.25	0.87	0.28	-0.62
Good Will	0.97	0.94	0.76	0.87	0.35	0.87	0.97	0.74	0.42	0.86	0.89	0.98	0.67		-0.79	0.45	0.16	0.79	0.26	0.1	-0.08	0.13	0.6	0.24	-0.15
Treasury Stock	-0.77	-0.8	-0.61	-0.89	-0.18	-0.7	-0.72	-0.6	-0.35	-0.72	-0.61	-0.73	-0.46	-0.79		-0.24	-0.3	-0.62	-0.6	-0.53	0.13	-0.25	-0.36	-0.2	0.1
Current Deferred Revenue	0.51	0.5	0.51	0.52	0.47	0.53	0.5	0.63	0.3	0.28	0.35	0.46	0.66	0.45	-0.24		0.43	0.54	0.14	-0.25	0.17	0.46	0.68	0.41	-0.39
Net Tangible Assets	0.35	0.43	0.0	0.37	0.11	0.5	0.27	0.65	0.0	-0.15	0.13	0.18	0.38	0.16	-0.3	0.43		0.51	0.36	0.39	-0.3	0.69	0.49	0.76	0.03
Long Term Debt Total	0.83	0.82	0.73	0.82	0.58	0.78	0.83	0.76	0.45	0.44	0.81	0.83	0.84	0.79	-0.62	0.54	0.51		0.39	0.15	-0.09	0.37	0.84	0.4	-0.37
Capital Surpluse	0.28	0.31	0.38	0.53	0.41	0.27	0.25	0.3	0.39	0.21	0.37	0.29	0.19	0.26	-0.6	0.14	0.36	0.39		0.65	0.22	0.41	0.37	0.1	-0.4
Long Term Investments	0.18	0.26	-0.14	0.24	-0.29	0.17	0.09	0.17	-0.12	0.16	0.07	0.13	-0.24	0.1	-0.53	-0.25	0.39	0.15	0.65		-0.3	0.27	-0.16	0.17	0.3
Short Long Term Debt	-0.14	-0.24	0.3	-0.04	0.41	-0.31	-0.04	-0.16	0.7	-0.09	0.11	-0.07	0.06	-0.08	0.13	0.17	-0.3	-0.09	0.22	-0.3		0.04	0.3	-0.45	-0.47
Cash And Equivalents	0.31	0.33	0.11	0.33	0.13	0.46	0.27	0.7	0.38	0.04	0.08	0.15	0.25	0.13	-0.25	0.46	0.69	0.37	0.41	0.27	0.04		0.4	0.76	-0.09
Net Invested Capital	0.64	0.6	0.75	0.69	0.81	0.61	0.66	0.68	0.62	0.21	0.71	0.63	0.87	0.6	-0.36	0.68	0.49	0.84	0.37	-0.16	0.3	0.4		0.34	-0.62
Net Working Capital	0.42	0.48	-0.03	0.3	-0.04	0.65	0.36	0.77	-0.03	0.08	0.13	0.24	0.28	0.24	-0.2	0.41	0.76	0.4	0.1	0.17	-0.45	0.76	0.34		0.18
Capital Stock	-0.05	-0.01	-0.72	-0.41	-0.94	-0.03	-0.08	-0.04	-0.52	0.02	-0.26	-0.15	-0.62	-0.15	0.1	-0.39	0.03	-0.37	-0.4	0.3	-0.47	-0.09	-0.62	0.18

Click cells to compare fundamentals

Quest Current Liabilities Historical Pattern

Today, most investors in Quest Diagnostics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Quest Diagnostics' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current liabilities growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Quest Diagnostics current liabilities as a starting point in their analysis.

Quest Diagnostics Current Liabilities

Timeline

Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.

Competition

Predict Quest Diagnostics

Total Current Liabilities Over Time

Quest Total Current Liabilities

Total Current Liabilities

1.28 Billion

At this time, Quest Diagnostics' Total Current Liabilities is fairly stable compared to the past year.

In accordance with the recently published financial statements, Quest Diagnostics Incorporated has a Current Liabilities of 1.17 B. This is 33.06% lower than that of the Health Care Providers & Services sector and 121.41% higher than that of the Health Care industry. The current liabilities for all United States stocks is 85.16% higher than that of the company.

Quest Current Liabilities Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Quest Diagnostics' direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Quest Diagnostics could also be used in its relative valuation, which is a method of valuing Quest Diagnostics by comparing valuation metrics of similar companies.

Quest Diagnostics is currently under evaluation in current liabilities category among its peers.

Quest Diagnostics ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Quest Diagnostics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Quest Diagnostics' managers, analysts, and investors.

Environmental

Governance

Social

Quest Fundamentals

	Return On Equity	0.14
	Return On Asset	0.0584
	Profit Margin	0.09 %
	Operating Margin	0.14 %
	Current Valuation	25.85 B
	Shares Outstanding	110.98 M
	Shares Owned By Insiders	0.89 %
	Shares Owned By Institutions	93.19 %
	Number Of Shares Shorted	2.58 M
	Price To Earning	14.57 X
	Price To Book	2.85 X
	Price To Sales	1.97 X
	Revenue	9.87 B
	Gross Profit	3.27 B
	EBITDA	1.91 B
	Net Income	921 M
	Cash And Equivalents	315 M
	Cash Per Share	6.15 X
	Total Debt	6.92 B
	Debt To Equity	0.73 %
	Current Ratio	1.46 X
	Book Value Per Share	61.06 X
	Cash Flow From Operations	1.33 B
	Short Ratio	2.52 X
	Earnings Per Share	7.69 X
	Price To Earnings To Growth	1.42 X
	Target Price	176.46
	Number Of Employees	45 K
	Beta	0.91
	Market Capitalization	19.47 B
	Total Asset	16.15 B
	Retained Earnings	9.36 B
	Working Capital	223 M
	Current Asset	1.5 B
	Current Liabilities	1.17 B
	Annual Yield	0.02 %
	Five Year Return	1.89 %
	Net Asset	16.15 B
	Last Dividend Paid	3.0

About Quest Diagnostics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Quest Diagnostics Incorporated's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Quest Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Quest Diagnostics Incorporated based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CRM	Salesforce
C	Citigroup
GM	General Motors

Additional Tools for Quest Stock Analysis

When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC